Slingshot members are tracking this event:
Galapagos inks $2.1B deal with Gilead to develop filgotinib for inflammatory conditions
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Dec 17, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Filgotinib, Crohn's Disease, Rheumatoid Arthritis